Literature DB >> 26972539

Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations.

Rima A Safadi1, Basma F Quda2, Huda M Hammad3.   

Abstract

OBJECTIVE: To identify cutoff values of markers that correlate with the histopathologic diagnosis of ameloblastic carcinoma (AC) and/or the increased recurrence potential of ameloblastoma (AB). STUDY
DESIGN: Immunohistochemical expression (IHCE) of 9 selected markers were investigated in 18 non-recurrent ameloblastomas (NRABs), 6 recurrent ameloblastomas (RABs), and 5 ACs.
RESULTS: No significant difference in IHCE of K6, K8, K16, K17, K18, K19, maspin, or syndecan-1 was observed among study groups. α Smooth muscle actin (α-SMA)-positive area in central epithelial cells significantly differentiated between AB and AC (P = .017; t -test). Ki-67 score significantly differentiated between AB and AC (P < .005; t -test) and between AC and RAB (P = .015; ANOVA/post hoc).
CONCLUSIONS: Ki-67 score of 75 cells/HPF (ROC curve) is a potential indicator of AC. Clinical recurrence of AB may be predicted by α-SMA expression pattern. Syndecan-1 and α-SMA may indicate a higher aggressive potential of AB when expressed in the stroma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26972539     DOI: 10.1016/j.oooo.2015.11.015

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

1.  Expression of keratin 15 in dentigerous cyst, odontogenic keratocyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Alaa Muayad Altaie; Shengrong Zhu
Journal:  Mol Clin Oncol       Date:  2019-01-17

2.  Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas.

Authors:  M Martínez-Martínez; A Mosqueda-Taylor; R Carlos-Bregni; F-R Pires; W Delgado-Azanero; R Neves-Silva; B Aldape-Barrios; O Paes-de Almeida
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

3.  Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.

Authors:  Ramón G Carreón-Burciaga; Rogelio González-González; Nelly Molina-Frechero; Sandra López-Verdín; Vanesa Pereira-Prado; Ronell Bologna-Molina
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-23       Impact factor: 2.916

Review 4.  Proteoglycans as potential biomarkers in odontogenic tumors.

Authors:  Zaira Gómez-Herrera; Nelly Molina-Frechero; Pablo Damián-Matsumura; Ronell Bologna-Molina
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

5.  Expression Profile of Stemness Markers CD138, Nestin and Alpha-SMA in Ameloblastic Tumours.

Authors:  Callisthenis Yiannis; Massimo Mascolo; Michele Davide Mignogna; Silvia Varricchio; Valentina Natella; Gaetano De Rosa; Roberto Lo Giudice; Cosimo Galletti; Rita Paolini; Antonio Celentano
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

6.  Hypoxia-induced HIF-1α and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF-β-dependent EMT.

Authors:  Shohei Yoshimoto; Fumie Tanaka; Hiromitsu Morita; Akimitsu Hiraki; Shuichi Hashimoto
Journal:  Cancer Med       Date:  2019-11-01       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.